Format
Sort by
Items per page

Send to

Choose Destination

Best matches for endocannabinoid system:

Endocannabinoid system in neurodegenerative disorders. Basavarajappa BS et al. J Neurochem. (2017)

Distribution of the Endocannabinoid System in the Central Nervous System. Hu SS et al. Handb Exp Pharmacol. (2015)

The Endocannabinoid System and its Modulation by Phytocannabinoids. Di Marzo V et al. Neurotherapeutics. (2015)

Search results

Items: 1 to 20 of 5043

1.

Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity.

Dimmito MP, Stefanucci A, Pieretti S, Minosi P, Dvorácskó S, Tömböly C, Zengin G, Mollica A.

Biomolecules. 2019 Sep 16;9(9). pii: E492. doi: 10.3390/biom9090492.

PMID:
31527522
2.

The Endocannabinoid System of Animals.

Silver RJ.

Animals (Basel). 2019 Sep 16;9(9). pii: E686. doi: 10.3390/ani9090686. Review.

PMID:
31527410
3.

Corrigendum to "Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system" [Biochem. Pharmacol. 161 (2019) 37-51].

Salaga M, Binienda A, Piscitelli F, Mokrowiecka A, Cygankiewicz AI, Verde R, Malecka-Panas E, Kordek R, Krajewska WM, Di Marzo V, Fichna J.

Biochem Pharmacol. 2019 Sep 14;169:113636. doi: 10.1016/j.bcp.2019.113636. [Epub ahead of print] No abstract available.

PMID:
31526940
4.

The cannabinoid agonist WIN-2 affects acquisition but not consolidation of a spatial information in training and retraining processes: relation with transcriptional regulation of the endocannabinoid system?

Alarcon TA, Areal LB, Herlinger AL, Paiva KK, Cicilini MA, Martins-Silva C, Pires RGW.

Behav Brain Res. 2019 Sep 14:112231. doi: 10.1016/j.bbr.2019.112231. [Epub ahead of print]

PMID:
31526770
5.

Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits.

Heilman P, Hill MN, Coussons-Read M, Brundin L, Coccaro EF.

Psychoneuroendocrinology. 2019 Sep 5;110:104434. doi: 10.1016/j.psyneuen.2019.104434. [Epub ahead of print]

PMID:
31525567
6.

Stress and drug abuse-related disorders: the promising therapeutic value of neurosteroids Focus on Pregnenolone-Progesterone-Allopregnanolone pathway.

Tomaselli G, Vallée M.

Front Neuroendocrinol. 2019 Sep 13:100789. doi: 10.1016/j.yfrne.2019.100789. [Epub ahead of print] Review.

PMID:
31525393
7.

Stress and Western diets increase vulnerability to neuropsychiatric disorders: A common mechanism.

Dagnino-Subiabre A.

Nutr Neurosci. 2019 Sep 16:1-11. doi: 10.1080/1028415X.2019.1661651. [Epub ahead of print]

PMID:
31524571
8.

Insights into the role of cannabis in the management of inflammatory bowel disease.

Picardo S, Kaplan GG, Sharkey KA, Seow CH.

Therap Adv Gastroenterol. 2019 Sep 3;12:1756284819870977. doi: 10.1177/1756284819870977. eCollection 2019. Review.

PMID:
31523278
9.

Effects of Cannabinoids on Female Sexual Function.

Lynn B, Gee A, Zhang L, Pfaus JG.

Sex Med Rev. 2019 Sep 11. pii: S2050-0521(19)30077-0. doi: 10.1016/j.sxmr.2019.07.004. [Epub ahead of print] Review.

10.

Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but Does Not Additively Reduce Body Weight or Eating.

Mani BK, Castorena CM, Vianna CR, Lee CE, Metzger NP, Vijayaraghavan P, Osborne-Lawrence S, Elmquist JK, Zigman JM.

Neuroscience. 2019 Sep 11. pii: S0306-4522(19)30650-5. doi: 10.1016/j.neuroscience.2019.09.005. [Epub ahead of print]

PMID:
31520709
11.

Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems.

Grillo A, Chemi G, Brogi S, Brindisi M, Relitti N, Fezza F, Fazio D, Castelletti L, Perdona E, Wong A, Lamponi S, Pecorelli A, Benedusi M, Fantacci M, Valoti M, Valacchi G, Micheli F, Novellino E, Campiani G, Butini S, Maccarrone M, Gemma S.

Eur J Med Chem. 2019 Sep 4;183:111674. doi: 10.1016/j.ejmech.2019.111674. [Epub ahead of print]

PMID:
31518969
12.

Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery.

Gado F, Meini S, Bertini S, Digiacomo M, Macchia M, Manera C.

Future Med Chem. 2019 Aug;11(15):2019-2037. doi: 10.4155/fmc-2019-0005.

PMID:
31517528
13.

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W.

Expert Rev Clin Immunol. 2019 Sep 12. doi: 10.1080/1744666X.2019.1665997. [Epub ahead of print]

PMID:
31512536
14.

Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity

Zhao W, Zimmermann K, Zhou X, Zhou F, Fu M, Dernbach C, Scheele D, Weber B, Eckstein M, Hurlemann R, Kendrick KM, Becker B.

J Psychiatry Neurosci. 2019 Sep 11;44(6):1-10. [Epub ahead of print]

15.

Endocannabinoid signaling as an intrinsic component of the circuits mediating adaptive responses to repeated stress exposure in adult male sprague dawley rats.

Newsom RJ, Stafford J, Garcia RJ, Campeau S.

Stress. 2019 Sep 11:1-16. doi: 10.1080/10253890.2019.1655538. [Epub ahead of print]

PMID:
31506004
16.

Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression.

Fitzgibbon M, Kerr DM, Henry RJ, Finn DP, Roche M.

Brain Behav Immun. 2019 Sep 7. pii: S0889-1591(19)30606-3. doi: 10.1016/j.bbi.2019.09.006. [Epub ahead of print]

PMID:
31505257
17.

Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes.

Rossi G, Gioacchini G, Pengo G, Suchodolski JS, Jergens AE, Allenspach K, Gavazza A, Scarpona S, Berardi S, Galosi L, Bassotti G, Cerquetella M.

Neurogastroenterol Motil. 2019 Sep 8:e13717. doi: 10.1111/nmo.13717. [Epub ahead of print]

PMID:
31495983
18.

Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.

Zhou H, Peng X, Hou T, Zhao N, Qiu M, Zhang X, Liang X.

J Ethnopharmacol. 2019 Sep 5:112218. doi: 10.1016/j.jep.2019.112218. [Epub ahead of print]

PMID:
31494202
19.

Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet.

Martin GG, Seeger DR, McIntosh AL, Milligan S, Chung S, Landrock D, Dangott LJ, Golovko MY, Murphy EJ, Kier AB, Schroeder F.

Lipids. 2019 Sep 5. doi: 10.1002/lipd.12192. [Epub ahead of print]

PMID:
31487051
20.

The "entourage effect": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders.

Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, Shbiro L, Weller A.

Curr Neuropharmacol. 2019 Sep 2. doi: 10.2174/1570159X17666190903103923. [Epub ahead of print]

PMID:
31481004

Supplemental Content

Loading ...
Support Center